In Section 2 and Section 3, along with the discussion on biological aspects of HER2 and the PD-L1 axis, we highlight how parallel theoretical analysis using mathematical modeling can contribute to improving the treatment of HER2+ BC. The gene discussed is ERBB2; the disease is breast cancer.